The stock price of TuHURA Biosciences Inc (NASDAQ: HURA) has dropped by -12.91 compared to previous close of 3.33. Despite this, the company has seen a fall of -30.79% in its stock price over the last five trading days. accessnewswire.com reported 2025-02-19 that On-demand video webcast now available here TAMPA, FL / ACCESS Newswire / February 19, 2025 / TuHURA Biosciences, Inc. (NASDAQ:HURA) (“TuHURA”), a Phase 3 registration-stage immune-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, today announced it participated in the Virtual Investor “Top 5 for ‘25” On-Demand Conference. As part of the event, James Bianco, M.D.
Is It Worth Investing in TuHURA Biosciences Inc (NASDAQ: HURA) Right Now?
The stock has a 36-month beta value of 0.97. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for HURA is 23.89M, and at present, short sellers hold a 3.95% of that float. On February 25, 2025, the average trading volume of HURA was 360.69K shares.
HURA’s Market Performance
HURA stock saw a decrease of -30.79% in the past week, with a monthly decline of -37.23% and a quarterly a decrease of -3.97%. The volatility ratio for the week is 14.16%, and the volatility levels for the last 30 days are 9.81% for TuHURA Biosciences Inc (HURA). The simple moving average for the last 20 days is -31.76% for HURA’s stock, with a simple moving average of -53.27% for the last 200 days.
Analysts’ Opinion of HURA
Many brokerage firms have already submitted their reports for HURA stocks, with Rodman & Renshaw repeating the rating for HURA by listing it as a “Buy.” The predicted price for HURA in the upcoming period, according to Rodman & Renshaw is $11 based on the research report published on December 19, 2024 of the previous year 2024.
Maxim Group, on the other hand, stated in their research note that they expect to see HURA reach a price target of $15. The rating they have provided for HURA stocks is “Buy” according to the report published on November 05th, 2024.
HURA Trading at -34.69% from the 50-Day Moving Average
After a stumble in the market that brought HURA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -80.13% of loss for the given period.
Volatility was left at 9.81%, however, over the last 30 days, the volatility rate increased by 14.16%, as shares sank -33.49% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -51.10% lower at present.
During the last 5 trading sessions, HURA fell by -30.79%, which changed the moving average for the period of 200-days by -42.86% in comparison to the 20-day moving average, which settled at $4.25. In addition, TuHURA Biosciences Inc saw -29.10% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for HURA
The total capital return value is set at -4.16. Equity return is now at value -370.77, with -163.44 for asset returns.
Currently, EBITDA for the company is -29.12 million with net debt to EBITDA at 0.39. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.45.
Conclusion
To sum up, TuHURA Biosciences Inc (HURA) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
